KORU Medical Systems Analyst Ratings
Craig-Hallum Maintains KORU Medical Systems(KRMD.US) With Buy Rating
Craig-Hallum Maintains KORU Medical Systems(KRMD.US) With Buy Rating
B.Riley Financial Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Maintains Target Price $4
Lake Street Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Maintains Target Price $4
KORU Medical Systems Promotes Christopher Pazdan to Chief Operating Officer Effective July 18 >KRMD
Buy Rating Affirmed for KORU Medical Systems Amidst Growth and Market Expansion Prospects
Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target
KORU Medical Systems Analyst Ratings
Lake Street Initiates Coverage On KORU Medical Systems With Buy Rating, Announces Price Target of $4
KORU Medical Systems Analyst Ratings
B. Riley Starts Repro Med Systems at Buy With $4.50 Price Target, Says Risk/Reward Becoming More Favorable
Piper Sandler Maintains Overweight on KORU Medical Systems, Lowers Price Target to $3
KORU Medical Systems Analyst Ratings
Piper Sandler Adjusts Repro Med Systems Price Target to $4.50 From $3.50, Maintains Overweight Rating
KORU Medical Systems Analyst Ratings
Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5
Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3
KORU Medical Systems Analyst Ratings
Piper Sandler Upgrades KORU Medical Systems to Overweight, Raises Price Target to $3.5
No Data
No Data